Since KSR2 genetic polymorphisms are linked to obesity/T2D in humans, our full understanding of how KSR2 differentially regulates general tissue adiposity versus bone marrow adiposity could lead to the identification of novel therapeutic strategies to promote bone health in humans with obesity/T2D. The gene discussed is KSR2; the disease is Obesity.